$204.29 0%
Price vs. AI Score (Last 150 days)
Data gathered: December 9

Data Bits

Data Bits Value / Change Benchmark
Job Posts N/A N/A
Sentiment N/A N/A
Webpage traffic N/A N/A
Employee Rating N/A N/A
Google Adspend $ N/A N/A
Google Trends N/A N/A
Linkedin Employees N/A N/A
Patents N/A N/A
4chan Mentions N/A N/A
Facebook Engagement N/A N/A
Facebook followers N/A N/A
Stocktwits Mentions N/A N/A
Stocktwits Subscribers N/A N/A
Twitter Followers N/A N/A
Youtube Subscribers N/A N/A
Instagram Followers N/A N/A
News Mentions N/A N/A
Reddit Mentions N/A N/A
Business outlook N/A N/A

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news


About Charles River Laboratories

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support.


Charles River Laboratories
Price $204.29
Target Price Sign up
Market Cap $10.4B
Dividend Yield 0.024
Industry Biotechnology

Similar companies

Company Price AI Score

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '231.02B225M790M87M180M
Q2 '231.05B234M815M97M196M
Q1 '231.03B652M378M103M200M
Q4 '221.23B246M986M187M316M
Q3 '22994M220M773M96M169M

Insider Transactions

LaPlume Joseph W filed to sell 23,133 shares at $197.7.
December 1 '23
Girshick Birgit filed to buy 44,449 shares at $187.8.
November 21 '23
LaPlume Joseph W filed to sell 24,983 shares at $173.8.
November 13 '23
WALLMAN RICHARD F filed to buy 1,000 shares at $198.8.
August 29 '23
LaPlume Joseph W filed to sell 24,983 shares at $216.5.
August 14 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.